NOVO-NORDISK A/S-SPONS ADR (NVO) Fundamental Analysis & Valuation
NYSE:NVO • US6701002056
Current stock price
36.04 USD
-0.36 (-0.99%)
At close:
36.06 USD
+0.02 (+0.06%)
After Hours:
This NVO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NVO Profitability Analysis
1.1 Basic Checks
- NVO had positive earnings in the past year.
- In the past year NVO had a positive cash flow from operations.
- In the past 5 years NVO has always been profitable.
- Each year in the past 5 years NVO had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of NVO (18.87%) is better than 96.89% of its industry peers.
- NVO's Return On Equity of 52.79% is amongst the best of the industry. NVO outperforms 98.45% of its industry peers.
- NVO has a Return On Invested Capital of 30.79%. This is amongst the best in the industry. NVO outperforms 98.45% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for NVO is significantly above the industry average of 13.06%.
- The last Return On Invested Capital (30.79%) for NVO is well below the 3 year average (43.61%), which needs to be investigated, but indicates that NVO had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.87% | ||
| ROE | 52.79% | ||
| ROIC | 30.79% |
ROA(3y)22.39%
ROA(5y)22.95%
ROE(3y)67.23%
ROE(5y)67.14%
ROIC(3y)43.61%
ROIC(5y)44.74%
1.3 Margins
- NVO has a Profit Margin of 33.14%. This is amongst the best in the industry. NVO outperforms 95.85% of its industry peers.
- In the last couple of years the Profit Margin of NVO has remained more or less at the same level.
- With an excellent Operating Margin value of 41.30%, NVO belongs to the best of the industry, outperforming 98.45% of the companies in the same industry.
- NVO's Operating Margin has been stable in the last couple of years.
- The Gross Margin of NVO (80.98%) is better than 85.49% of its industry peers.
- In the last couple of years the Gross Margin of NVO has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 41.3% | ||
| PM (TTM) | 33.14% | ||
| GM | 80.98% |
OM growth 3Y-1.15%
OM growth 5Y-0.81%
PM growth 3Y1.84%
PM growth 5Y-0.03%
GM growth 3Y-1.18%
GM growth 5Y-0.61%
2. NVO Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NVO is creating value.
- Compared to 1 year ago, NVO has about the same amount of shares outstanding.
- Compared to 5 years ago, NVO has more shares outstanding
- The debt/assets ratio for NVO is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 3.55 indicates that NVO is not in any danger for bankruptcy at the moment.
- NVO has a better Altman-Z score (3.55) than 72.02% of its industry peers.
- NVO has a debt to FCF ratio of 4.52. This is a neutral value as NVO would need 4.52 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 4.52, NVO belongs to the best of the industry, outperforming 84.46% of the companies in the same industry.
- NVO has a Debt/Equity ratio of 0.61. This is a neutral value indicating NVO is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.61, NVO is not doing good in the industry: 65.28% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 4.52 | ||
| Altman-Z | 3.55 |
ROIC/WACC4.53
WACC6.79%
2.3 Liquidity
- A Current Ratio of 0.80 indicates that NVO may have some problems paying its short term obligations.
- NVO has a worse Current ratio (0.80) than 87.05% of its industry peers.
- A Quick Ratio of 0.57 indicates that NVO may have some problems paying its short term obligations.
- NVO has a Quick ratio of 0.57. This is amonst the worse of the industry: NVO underperforms 86.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.8 | ||
| Quick Ratio | 0.57 |
3. NVO Growth Analysis
3.1 Past
- NVO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.77%.
- The Earnings Per Share has been growing by 20.66% on average over the past years. This is a very strong growth
- The Revenue has been growing slightly by 6.43% in the past year.
- Measured over the past years, NVO shows a quite strong growth in Revenue. The Revenue has been growing by 19.48% on average per year.
EPS 1Y (TTM)1.77%
EPS 3Y23.52%
EPS 5Y20.66%
EPS Q2Q%-4.73%
Revenue 1Y (TTM)6.43%
Revenue growth 3Y20.43%
Revenue growth 5Y19.48%
Sales Q2Q%-7.63%
3.2 Future
- NVO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.80% yearly.
- The Revenue is expected to grow by 4.07% on average over the next years.
EPS Next Y-3.96%
EPS Next 2Y-2.8%
EPS Next 3Y1.16%
EPS Next 5Y5.8%
Revenue Next Year-4.65%
Revenue Next 2Y-0.75%
Revenue Next 3Y1.62%
Revenue Next 5Y4.07%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. NVO Valuation Analysis
4.1 Price/Earnings Ratio
- NVO is valuated reasonably with a Price/Earnings ratio of 10.12.
- NVO's Price/Earnings ratio is rather cheap when compared to the industry. NVO is cheaper than 89.64% of the companies in the same industry.
- When comparing the Price/Earnings ratio of NVO to the average of the S&P500 Index (24.88), we can say NVO is valued rather cheaply.
- With a Price/Forward Earnings ratio of 10.53, the valuation of NVO can be described as very reasonable.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of NVO indicates a rather cheap valuation: NVO is cheaper than 86.53% of the companies listed in the same industry.
- NVO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.19.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.12 | ||
| Fwd PE | 10.53 |
4.2 Price Multiples
- 91.71% of the companies in the same industry are more expensive than NVO, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, NVO is valued a bit cheaper than the industry average as 78.76% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.78 | ||
| EV/EBITDA | 7.69 |
4.3 Compensation for Growth
- The excellent profitability rating of NVO may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.49
EPS Next 2Y-2.8%
EPS Next 3Y1.16%
5. NVO Dividend Analysis
5.1 Amount
- NVO has a Yearly Dividend Yield of 4.91%, which is a nice return.
- In the last 3 months the price of NVO has falen by -31.22%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- NVO's Dividend Yield is rather good when compared to the industry average which is at 0.70. NVO pays more dividend than 96.89% of the companies in the same industry.
- NVO's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.91% |
5.2 History
- On average, the dividend of NVO grows each year by 19.05%, which is quite nice.
- NVO has paid a dividend for at least 10 years, which is a reliable track record.
- NVO has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)19.05%
Div Incr Years7
Div Non Decr Years7
5.3 Sustainability
- 50.53% of the earnings are spent on dividend by NVO. This is a bit on the high side, but may be sustainable.
- NVO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP50.53%
EPS Next 2Y-2.8%
EPS Next 3Y1.16%
NVO Fundamentals: All Metrics, Ratios and Statistics
36.04
-0.36 (-0.99%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-03 2026-02-03/amc
Earnings (Next)05-06 2026-05-06
Inst Owners32.22%
Inst Owner Change3.18%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap160.19B
Revenue(TTM)309.06B
Net Income(TTM)102.43B
Analysts69.41
Price Target57.95 (60.79%)
Short Float %0.68%
Short Ratio1.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.91% |
Yearly Dividend1.8
Dividend Growth(5Y)19.05%
DP50.53%
Div Incr Years7
Div Non Decr Years7
Ex-Date03-30 2026-03-30 (1.275101)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.82%
Min EPS beat(2)-7.04%
Max EPS beat(2)1.39%
EPS beat(4)2
Avg EPS beat(4)-0.71%
Min EPS beat(4)-7.04%
Max EPS beat(4)3.94%
EPS beat(8)5
Avg EPS beat(8)1.01%
EPS beat(12)8
Avg EPS beat(12)1.47%
EPS beat(16)11
Avg EPS beat(16)1.68%
Revenue beat(2)1
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-3.19%
Max Revenue beat(2)1.07%
Revenue beat(4)1
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)1.07%
Revenue beat(8)3
Avg Revenue beat(8)0.15%
Revenue beat(12)6
Avg Revenue beat(12)0.52%
Revenue beat(16)9
Avg Revenue beat(16)0.84%
PT rev (1m)-9.11%
PT rev (3m)-11.49%
EPS NQ rev (1m)12.4%
EPS NQ rev (3m)0.88%
EPS NY rev (1m)-2.86%
EPS NY rev (3m)-7.3%
Revenue NQ rev (1m)1.33%
Revenue NQ rev (3m)-50.96%
Revenue NY rev (1m)-0.77%
Revenue NY rev (3m)-6.85%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.12 | ||
| Fwd PE | 10.53 | ||
| P/S | 3.36 | ||
| P/FCF | 35.78 | ||
| P/OCF | 8.71 | ||
| P/B | 5.35 | ||
| P/tB | 16.21 | ||
| EV/EBITDA | 7.69 |
EPS(TTM)3.56
EY9.88%
EPS(NY)3.42
Fwd EY9.49%
FCF(TTM)1.01
FCFY2.79%
OCF(TTM)4.14
OCFY11.48%
SpS10.74
BVpS6.74
TBVpS2.22
PEG (NY)N/A
PEG (5Y)0.49
Graham Number23.24
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.87% | ||
| ROE | 52.79% | ||
| ROCE | 39.01% | ||
| ROIC | 30.79% | ||
| ROICexc | 33.56% | ||
| ROICexgc | 59.2% | ||
| OM | 41.3% | ||
| PM (TTM) | 33.14% | ||
| GM | 80.98% | ||
| FCFM | 9.38% |
ROA(3y)22.39%
ROA(5y)22.95%
ROE(3y)67.23%
ROE(5y)67.14%
ROIC(3y)43.61%
ROIC(5y)44.74%
ROICexc(3y)50.94%
ROICexc(5y)53.03%
ROICexgc(3y)100.46%
ROICexgc(5y)105.49%
ROCE(3y)55.75%
ROCE(5y)58.53%
ROICexgc growth 3Y-22.89%
ROICexgc growth 5Y-7.78%
ROICexc growth 3Y-18.13%
ROICexc growth 5Y-11.63%
OM growth 3Y-1.15%
OM growth 5Y-0.81%
PM growth 3Y1.84%
PM growth 5Y-0.03%
GM growth 3Y-1.18%
GM growth 5Y-0.61%
F-Score5
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 4.52 | ||
| Debt/EBITDA | 0.79 | ||
| Cap/Depr | 409.94% | ||
| Cap/Sales | 29.16% | ||
| Interest Coverage | 37.34 | ||
| Cash Conversion | 79.59% | ||
| Profit Quality | 28.3% | ||
| Current Ratio | 0.8 | ||
| Quick Ratio | 0.57 | ||
| Altman-Z | 3.55 |
F-Score5
WACC6.79%
ROIC/WACC4.53
Cap/Depr(3y)363.9%
Cap/Depr(5y)282.93%
Cap/Sales(3y)21.19%
Cap/Sales(5y)15.43%
Profit Quality(3y)60.31%
Profit Quality(5y)79.23%
High Growth Momentum
Growth
EPS 1Y (TTM)1.77%
EPS 3Y23.52%
EPS 5Y20.66%
EPS Q2Q%-4.73%
EPS Next Y-3.96%
EPS Next 2Y-2.8%
EPS Next 3Y1.16%
EPS Next 5Y5.8%
Revenue 1Y (TTM)6.43%
Revenue growth 3Y20.43%
Revenue growth 5Y19.48%
Sales Q2Q%-7.63%
Revenue Next Year-4.65%
Revenue Next 2Y-0.75%
Revenue Next 3Y1.62%
Revenue Next 5Y4.07%
EBIT growth 1Y-4.76%
EBIT growth 3Y19.04%
EBIT growth 5Y18.51%
EBIT Next Year8.51%
EBIT Next 3Y5.92%
EBIT Next 5Y7.75%
FCF growth 1Y-58.38%
FCF growth 3Y-23.26%
FCF growth 5Y-0.6%
OCF growth 1Y-1.54%
OCF growth 3Y14.72%
OCF growth 5Y18.05%
NOVO-NORDISK A/S-SPONS ADR / NVO Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for NOVO-NORDISK A/S-SPONS ADR?
ChartMill assigns a fundamental rating of 6 / 10 to NVO.
What is the valuation status of NOVO-NORDISK A/S-SPONS ADR (NVO) stock?
ChartMill assigns a valuation rating of 7 / 10 to NOVO-NORDISK A/S-SPONS ADR (NVO). This can be considered as Undervalued.
Can you provide the profitability details for NOVO-NORDISK A/S-SPONS ADR?
NOVO-NORDISK A/S-SPONS ADR (NVO) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for NVO stock?
The Price/Earnings (PE) ratio for NOVO-NORDISK A/S-SPONS ADR (NVO) is 10.12 and the Price/Book (PB) ratio is 5.35.
What is the financial health of NOVO-NORDISK A/S-SPONS ADR (NVO) stock?
The financial health rating of NOVO-NORDISK A/S-SPONS ADR (NVO) is 4 / 10.